nach oben

hautnah

Erschienen in:

19.07.2022 | Umweltmedizin | UV-Filter

Sonnenschutz der Zukunft: Herausforderungen und Möglichkeiten

verfasst von: Univ.-Prof. Dr. Peter Wolf, Univ.-Prof. Dr. Jean Krutmann

Erschienen in: hautnah | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

Sonnenschutzmittel schützen hervorragend gegen Erythem und gegen chronische Schäden wie die Lichtalterung (Photoaging) und Hautkrebs. Aktuelle Herausforderungen betreffen die Sicherheit der Produkte und verbesserte Methoden, um ihre Wirksamkeit standardisiert zu bewerten. Weitere wichtige Themen sind die Weiterentwicklung von Sonnenschutzmitteln sowie die Personalisierung der Anwendung. Personalisierter Lichtschutz, der auf dem Phänotyp, den genetischen Profilen und darüberhinausgehend dem Mikrobiom der Haut – allesamt verbunden mit der Identifikation von bestimmten Suszeptibilitätsfaktoren der Verbraucher – beruht, ist ein spannendes neues Forschungsfeld. Insbesondere die Erweiterung mit innovativen topischen Agenzien wie DNS(Desoxyribonukleinsäure)-Reparatur-Liposomen in verbesserten galenischen Formulierungen mit auf den Hauttyp abgestimmten UV-Filtern und neuen topischen Antioxidanzien könnte zukünftig einen noch umfassenderen Sonnenschutz ermöglichen. Neue Antioxidanzien und andere Agenzien wie beispielsweise Nicotinamid könnten die systemische Photoprävention noch verstärken. Nachhaltigkeit wird zudem ein wichtiger Aspekt, um die Verbraucher, aber auch die Umwelt (d. h. insbesondere die marine Tier- und Pflanzenwelt) vor toxischen Auswirkungen von Sonnenschutzmitteln zu bewahren.

Autier P, Doré JF (2020) Ultraviolet radiation and cutaneous melanoma: a historical perspective. Melanoma Res 30:113–125PubMedCrossRef

Battie C, Jitsukawa S, Bernerd F et al (2014) New insights in photoaging, UVA induced damage and skin types. Exp Dermatol 23(1):7–12PubMedCrossRef

Boukari F, Jourdan E, Fontas E et al (2015) Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light: a prospective randomized comparative trial. J Am Acad Dermatol 72:189–190.e1PubMedCrossRef

Calzavara-Pinton PG, Arisi M, Wolf P (2019) Sunbeds and carcinogenesis: the need for new regulations and restrictions in Europe from the Euromelanoma perspective. J Eur Acad Dermatol Venereol 33(2):104–109PubMedCrossRef

Carducci M, Pavone PS, De Marco G et al (2015) Comparative effects of sunscreens alone vs sunscreen plus DNA repair enzymes in patients with actinic keratosis: clinical and molecular findings from a 6-month, randomized, clinical study. J Drugs Dermatol 14:986–990PubMed

Chen AC, Martin AJ, Choy B et al (2015) A phase 3 randomized trial of nicotinamide for skin-cancer chemoprevention. N Engl J Med 373:1618–1626PubMedCrossRef

Darlington S, Williams G, Neale R et al (2003) A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol 139:451–455PubMedCrossRef

Deboyes T, Kouba D, Ozog D et al (2010) Reduced number of actinic keratoses with topical application of DNA repair enzyme creams. J Drugs Dermatol 9:1519–1521PubMed

Duteil L, Cardot-Leccia N, Queille-Roussel C et al (2014) Differences in visible light-induced pigmentation according to wavelengths: a clinical and histological study in comparison with UVB exposure. Pigment Cell Melanoma Res 27:822–826PubMedCrossRef

10.

Duteil L, Esdaile J, Maubert Y et al (2017) A method to assess the protective efficacy of sunscreens against visible light-induced pigmentation. Photodermatol Photoimmunol Photomed 33:260–266PubMedCrossRef

11.

Eibenschutz L, Silipo V, De Simone P et al (2016) A 9‑month, randomized, assessor-blinded, parallel-group study to evaluate clinical effects of film-forming medical devices containing photolyase and sun filters in the treatment of field cancerization compared with sunscreen in patients after successful photodynamic therapy for actinic keratosis. Br J Dermatol 175:1391–1393PubMedCrossRef

12.

Emanuele E, Altabas V, Altabas K et al (2013) Topical application of preparations containing DNA repair enzymes prevents ultraviolet-induced telomere shortening and c‑FOS proto-oncogene hyperexpression in human skin: an experimental pilot study. J Drugs Dermatol 12:1017–1021PubMed

13.

Fourtanier A, Moyal D, Maccario J et al (2005) Measurement of sunscreen immune protection factors in humans: a consensus paper. J Invest Dermatol 125:403–409PubMedCrossRef

14.

Geisler AN, Austin E, Nguyen J et al (2021) Visible light. Part II: photoprotection against visible and ultraviolet light. J Am Acad Dermatol 84:1233–1244PubMedPubMedCentralCrossRef

15.

Gilchrest BA, Zhai S, Eller MS et al (1993) Treatment of human melanocytes and S91 melanoma cells with the DNA repair enzyme T4 endonuclease V enhances melanogenesis after ultraviolet irradiation. J Invest Dermatol 101:666–672PubMedCrossRef

16.

Green A, Williams G, Neale R et al (1999) Daily sunscreen application and betacarotene supplementation in prevention of basal-cell and squamous-cell carcinomas of the skin: a randomised controlled trial. Lancet 354:723–729PubMedCrossRef

17.

Green AC, Williams GM, Logan V et al (2011) Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol 29:257–263PubMedCrossRef

18.

Grether-Beck S, Marini A, Jaenicke T et al (2015) Effective photoprotection of human skin against infrared a radiation by topically applied antioxidants: results from a vehicle controlled, double-blind, randomized study. Photochem Photobiol 91:248–250PubMedCrossRef

19.

Grether-Beck S, Marini A, Jaenicke T et al (2017) Molecular evidence that oral supplementation with lycopene or lutein protects human skin against ultraviolet radiation: results from a double-blinded, placebo-controlled, crossover study. Br J Dermatol 176:1231–1240PubMedCrossRef

20.

Hirst NG, Gordon LG, Scuffham PA et al (2012) Lifetime cost-effectiveness of skin cancer prevention through promotion of daily sunscreen use. Value Health 15:261–268PubMedCrossRef

21.

Hofer A, Legat FJ, Gruber-Wackernagel A et al (2011) Topical liposomal DNA-repair enzymes in polymorphic light eruption. Photochem Photobiol Sci 10:1118–1128PubMedCrossRef

22.

Kabir Y, Seidel R, Mcknight B et al (2015) DNA repair enzymes: an important role in skin cancer prevention and reversal of photodamage—a review of the literature. J Drugs Dermatol 14:297–303PubMed

23.

Kohli I, Chaowattanapanit S, Mohammad TF et al (2018) Synergistic effects of long-wavelength ultraviolet A1 and visible light on pigmentation and erythema. Br J Dermatol 178:1173–1180PubMedCrossRef

24.

Kohli I, Shafi R, Isedeh P et al (2017) The impact of oral polypodium leucotomos extract on ultraviolet B response: a human clinical study. J Am Acad Dermatol 77:33–41.e1PubMedPubMedCentralCrossRef

25.

Köpcke W, Krutmann J (2008) Protection from sunburn with beta-carotene—a meta-analysis. Photochem Photobiol 84:284–288PubMedCrossRef

26.

Krutmann J (2000) Ultraviolet A radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis. J Dermatol Sci 23(1):S22–26PubMedCrossRef

27.

Krutmann J, Passeron T, Gilaberte Y et al (2020) Photoprotection of the future: challenges and opportunities. J Eur Acad Dermatol Venereol 34:447–454PubMedCrossRef

28.

Langendonk JG, Balwani M, Anderson KE et al (2015) Afamelanotide for erythropoietic protoporphyria. N Engl J Med 373:48–59PubMedPubMedCentralCrossRef

29.

Lim HW, Arellano-Mendoza MI, Stengel F (2017) Current challenges in photoprotection. J Am Acad Dermatol 76:S91–S99PubMedCrossRef

30.

Lyons AB, Trullas C, Kohli I et al (2021) Photoprotection beyond ultraviolet radiation: a review of tinted sunscreens. J Am Acad Dermatol 84:1393–1397PubMedCrossRef

31.

Mahmoud BH, Ruvolo E, Hexsel CL et al (2010) Impact of long-wavelength UVA and visible light on melanocompetent skin. J Invest Dermatol 130:2092–2097PubMedCrossRef

32.

Matta MK, Zusterzeel R, Pilli NR et al (2019) Effect of sunscreen application under maximal use conditions on plasma concentration of sunscreen active ingredients: a randomized clinical trial. JAMA 321:2082–2091PubMedPubMedCentralCrossRef

33.

Mitchelmore CL, He K, Gonsior M et al (2019) Occurrence and distribution of UV-filters and other anthropogenic contaminants in coastal surface water, sediment, and coral tissue from Hawaii. Sci Total Environ 670:398–410PubMedCrossRef

34.

Osterwalder U, Herzog B (2009) Sun protection factors: world wide confusion. Br J Dermatol 161(3):13–24PubMedCrossRef

35.

Ou-Yang H, Stanfield J, Cole C et al (2012) High-SPF sunscreens (SPF ≥ 70) may provide ultraviolet protection above minimal recommended levels by adequately compensating for lower sunscreen user application amounts. J Am Acad Dermatol 67:1220–1227PubMedCrossRef

36.

Passeron T, Bouillon R, Callender V et al (2019) Sunscreen photoprotection and vitamin D status. Br J Dermatol 181:916–931PubMedPubMedCentralCrossRef

37.

Passeron T, Nouveau S, Duval C et al (2018) Development and validation of a reproducible model for studying post-inflammatory hyperpigmentation. Pigment Cell Melanoma Res 31:649–652PubMedCrossRef

38.

Passeron T, Picardo M (2018) Melasma, a photoaging disorder. Pigment Cell Melanoma Res 31:461–465PubMedCrossRef

39.

Patel S, Watchmaker JD, Dover JS (2021) Darker skin types are underrepresented in sunscreen clinical trials: results of a literature review. J Am Acad Dermatol. https://doi.org/10.1016/j.jaad.2021.11.009CrossRefPubMedPubMedCentral

40.

Patra V, Trajanoski S, Braun C et al (2021) 231 cis-urocanic acid mediated cutaneous immune suppression is controlled by microbiome. J Invest Dermatol 141:S188CrossRef

41.

Patra V, Wagner K, Arulampalam V et al (2019) Skin microbiome modulates the effect of ultraviolet radiation on cellular response and immune function. iScience 15:211–222PubMedPubMedCentralCrossRef

42.

Premi S, Wallisch S, Mano CM et al (2015) Photochemistry. Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Science 347:842–847PubMedPubMedCentralCrossRef

43.

Puig S, Granger C, Garre A et al (2019) Review of clinical evidence over 10 years on prevention and treatment of a film-forming medical device containing photolyase in the management of field cancerization in actinic keratosis. Dermatol Ther (Heidelb) 9:259–270CrossRef

44.

Puviani M, Barcella A, Milani M (2013) Efficacy of a photolyase-based device in the treatment of cancerization field in patients with actinic keratosis and non-melanoma skin cancer. G Ital Dermatol Venereol 148:693–698PubMed

45.

Regazzetti C, Sormani L, Debayle D et al (2018) Melanocytes sense blue light and regulate pigmentation through opsin‑3. J Invest Dermatol 138:171–178PubMedCrossRef

46.

Rigel DS, Lim HW, Draelos ZD et al (2022) Photoprotection for all: current gaps and opportunities. J Am Acad Dermatol 86(3S):S18–S26. https://doi.org/10.1016/j.jaad.2021.12.023CrossRefPubMed

47.

Rohr M, Ernst N, Schrader A (2018) Hybrid diffuse reflectance spectroscopy: non-erythemal in vivo testing of sun protection factor. Skin Pharmacol Physiol 31:220–228PubMedCrossRef

48.

Schalka S (2017) New data on hyperpigmentation disorders. J Eur Acad Dermatol Venereol 31(5):18–21PubMedCrossRef

49.

Schalka S, Reis VM (2011) Sun protection factor: meaning and controversies. An Bras Dermatol 86:507–515PubMedCrossRef

50.

Schneider SL, Lim HW (2019) Review of environmental effects of oxybenzone and other sunscreen active ingredients. J Am Acad Dermatol 80:266–271PubMedCrossRef

51.

Schroeder P, Lademann J, Darvin ME et al (2008) Infrared radiation-induced matrix metalloproteinase in human skin: implications for protection. J Invest Dermatol 128:2491–2497PubMedCrossRef

52.

Singer S, Karrer S, Berneburg M (2019) Modern sun protection. Curr Opin Pharmacol 46:24–28PubMedCrossRef

53.

Stege H, Roza L, Vink AA et al (2000) Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A 97:1790–1795PubMedPubMedCentralCrossRef

54.

Trullàs C, Granger C, Lim HW et al (2020) Linear and exponential sunscreen behaviours as an explanation for observed discrepancies in sun protection factor testing. Photodermatol Photoimmunol Photomed 36:351–356PubMedCrossRef

55.

van der Pols JC, Williams GM, Pandeya N et al (2006) Prolonged prevention of squamous cell carcinoma of the skin by regular sunscreen use. Cancer Epidemiol Biomarkers Prev 15:2546–2548PubMedCrossRef

56.

Wang SQ, Virmani P, Lim HW (2016) Consumer acceptability and compliance: the next frontier in sunscreen innovation. Photodermatol Photoimmunol Photomed 32:55–56PubMedCrossRef

57.

Williams JD, Maitra P, Atillasoy E et al (2018) SPF 100+ sunscreen is more protective against sunburn than SPF 50+ in actual use: results of a randomized, double-blind, split-face, natural sunlight exposure clinical trial. J Am Acad Dermatol 78:902–910.e2PubMedCrossRef

58.

Wolber R, Schlenz K, Wakamatsu K et al (2008) Pigmentation effects of solar-simulated radiation as compared with UVA and UVB radiation. Pigment Cell Melanoma Res 21:487–491PubMedPubMedCentralCrossRef

59.

Wolf P (2013) Oral vitamin D supplementation vs. ultraviolet B exposure: what is appropriate to achieve a sufficient vitamin D level? Br J Dermatol 169:239PubMedCrossRef

60.

Wolf P (2019) Vitamin D: one more argument for broad-spectrum ultraviolet A + ultraviolet B sunscreen protection. Br J Dermatol 181:881–882PubMedCrossRef

61.

Wolf P, Cox P, Yarosh DB et al (1995) Sunscreens and T4N5 liposomes differ in their ability to protect against ultraviolet-induced sunburn cell formation, alterations of dendritic epidermal cells, and local suppression of contact hypersensitivity. J Invest Dermatol 104:287–292PubMedCrossRef

62.

Wolf P, Hoffmann C, Quehenberger F et al (2003) Immune protection factors of chemical sunscreens measured in the local contact hypersensitivity model in humans. J Invest Dermatol 121:1080–1087PubMedCrossRef

63.

Wolf P, Maier H, Mullegger RR et al (2000) Topical treatment with liposomes containing T4 endonuclease V protects human skin in vivo from ultraviolet-induced upregulation of interleukin-10 and tumor necrosis factor-alpha. J Invest Dermatol 114:149–156PubMedCrossRef

64.

Wulff BC, Schick JS, Thomas-Ahner JM et al (2008) Topical treatment with OGG1 enzyme affects UVB-induced skin carcinogenesis. Photochem Photobiol 84:317–321PubMedCrossRef

65.

Yamaguchi Y, Takahashi K, Zmudzka BZ et al (2006) Human skin responses to UV radiation: pigment in the upper epidermis protects against DNA damage in the lower epidermis and facilitates apoptosis. Faseb J 20:1486–1488PubMedCrossRef

66.

Yarosh DB, Canning MT, Teicher D et al (2005) After sun reversal of DNA damage: enhancing skin repair. Mutat Res 571:57–64PubMedCrossRef

67.

Yarosh DB, O’connor A, Alas L et al (1999) Photoprotection by topical DNA repair enzymes: molecular correlates of clinical studies. Photochem Photobiol 69:136–140PubMed

68.

Yarosh DB, Rosenthal A, Moy R (2019) Six critical questions for DNA repair enzymes in skincare products: a review in dialog. Clin Cosmet Investig Dermatol 12:617–624PubMedPubMedCentralCrossRef

69.

Young AR, Narbutt J, Harrison GI et al (2019) Optimal sunscreen use, during a sun holiday with a very high ultraviolet index, allows vitamin D synthesis without sunburn. Br J Dermatol 181:1052–1062PubMedPubMedCentralCrossRef

Titel: Sonnenschutz der Zukunft: Herausforderungen und Möglichkeiten
verfasst von: Univ.-Prof. Dr. Peter Wolf
Univ.-Prof. Dr. Jean Krutmann
Publikationsdatum: 19.07.2022
Verlag: Springer Vienna
Schlagwörter: Umweltmedizin
Erkrankungen durch Umwelteinflüsse
Hygiene- und Umweltmedizin
Melanom
Risikofaktoren für Krebserkrankungen
Erytheme
Erschienen in: hautnah / Ausgabe 4/2022
Print ISSN: 1866-2250
Elektronische ISSN: 2192-6484
DOI: https://doi.org/10.1007/s12326-022-00520-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Sonnenschutz der Zukunft: Herausforderungen und Möglichkeiten

Zusammenfassung

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2022

Oraler Lichen planus

Milben: Der Feind daheim

Lichen sclerosus et atrophicus präpubertal und postmenopausal

Schlechteres Gesamtüberleben mit Vitamin-D-Mangel

Hautmikrobiom als Faktor bei Stammzelltransplantationen

Können Sie mal kurz schauen, ob das was Schlimmes ist?

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Update Innere Medizin